These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9267680)

  • 1. Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view.
    Mahmood I
    Biopharm Drug Dispos; 1997 Aug; 18(6):465-73. PubMed ID: 9267680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary 'Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical review' (I. Mahmood).
    Hinderling PH
    Biopharm Drug Dispos; 1997 Dec; 18(9):821-4. PubMed ID: 9429745
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of sematilide in renal failure.
    Shi J; Ripley E; Gehr TW; Sica DA; Dandekar KA; Hinderling PH
    J Clin Pharmacol; 1996 Feb; 36(2):131-43. PubMed ID: 8852389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers.
    Miller AK; DiCicco RA; Freed MI
    Clin Ther; 2002 Jul; 24(7):1062-71. PubMed ID: 12182252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the absolute bioavailability of flecainide using stable isotope technique.
    Hage K; Bühl K; Fischer C; Knebel NG
    Eur J Clin Pharmacol; 1995; 48(1):51-5. PubMed ID: 7621848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function.
    Aronoff G; Brier M; Mayer ML; Barbalas M; Aogaichi K; Sloan R; Brazzell R; Massarella J
    J Clin Pharmacol; 1991 Jan; 31(1):38-44. PubMed ID: 2045527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to the comments on the commentary 'Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view'.
    Mahmood I
    Biopharm Drug Dispos; 1998 Oct; 19(7):483-4. PubMed ID: 9818716
    [No Abstract]   [Full Text] [Related]  

  • 10. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and pharmacokinetics of enoxacin.
    Nakamura S; Kurobe N; Sekine Y
    J Chemother; 1989 Jul; 1(4 Suppl):543-4. PubMed ID: 16312524
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
    Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE
    Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females.
    Ashiru DA; Patel R; Basit AW
    Pharm Res; 2008 Oct; 25(10):2327-33. PubMed ID: 18600434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
    Schaiquevich P; Niselman A; Rubio M
    Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a novel method to estimate absolute bioavailability of drugs from oral data.
    Hinderling PH
    Biopharm Drug Dispos; 2003 Jan; 24(1):1-16. PubMed ID: 12516074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patients.
    Kanji S; McKinnon PS; Barletta JF; Kruse JA; Devlin JW
    Crit Care Med; 2003 May; 31(5):1347-52. PubMed ID: 12771601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nizatidine disposition in subjects with normal and impaired renal function.
    Aronoff GR; Bergstrom RF; Bopp RJ; Sloan RS; Callaghan JT
    Clin Pharmacol Ther; 1988 Jun; 43(6):688-95. PubMed ID: 2897890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interactions between NSAIDs (indomethacin or sulindac) and H2-receptor antagonists (cimetidine or ranitidine) in human volunteers.
    Delhotal-Landes B; Flouvat B; Liote F; Abel L; Meyer P; Vinceneux P; Carbon C
    Clin Pharmacol Ther; 1988 Oct; 44(4):442-52. PubMed ID: 2901930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies.
    Yeh KC; Chremos AN; Lin JH; Constanzer ML; Kanovsky SM; Hucker HB; Antonello J; Vlasses P; Ryan JR; Williams RL
    Biopharm Drug Dispos; 1987; 8(6):549-60. PubMed ID: 2892544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.